COSMOS Pharmaceutical Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and COSMOS Pharmaceutical are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days COSMOS Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, COSMOS Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 55.1 B | |
| Total Cashflows From Investing Activities | -43.7 B |
COSMOS |
COSMOS Pharmaceutical Relative Risk vs. Return Landscape
If you would invest (100.00) in COSMOS Pharmaceutical on October 30, 2025 and sell it today you would earn a total of 100.00 from holding COSMOS Pharmaceutical or generate -100.0% return on investment over 90 days. COSMOS Pharmaceutical is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than COSMOS, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
COSMOS Pharmaceutical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of COSMOS Pharmaceutical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for COSMOS Pharmaceutical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| COSMOS Pharmaceutical is not yet fully synchronised with the market data | |
| COSMOS Pharmaceutical has some characteristics of a very speculative penny stock | |
| COSMOS Pharmaceutical has a very high chance of going through financial distress in the upcoming years | |
| About 51.0% of the company shares are held by company insiders |
COSMOS Pharmaceutical Fundamentals Growth
COSMOS Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of COSMOS Pharmaceutical, and COSMOS Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on COSMOS Pink Sheet performance.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0521 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 3.89 B | |||
| Shares Outstanding | 39.6 M | |||
| Price To Book | 2.72 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 755.41 B | |||
| EBITDA | 48.21 B | |||
| Total Debt | 3 B | |||
| Book Value Per Share | 5,056 X | |||
| Cash Flow From Operations | 32.19 B | |||
| Earnings Per Share | 4.54 X | |||
| Total Asset | 363.05 B | |||
Things to note about COSMOS Pharmaceutical performance evaluation
Checking the ongoing alerts about COSMOS Pharmaceutical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for COSMOS Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| COSMOS Pharmaceutical is not yet fully synchronised with the market data | |
| COSMOS Pharmaceutical has some characteristics of a very speculative penny stock | |
| COSMOS Pharmaceutical has a very high chance of going through financial distress in the upcoming years | |
| About 51.0% of the company shares are held by company insiders |
- Analyzing COSMOS Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether COSMOS Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining COSMOS Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating COSMOS Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of COSMOS Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of COSMOS Pharmaceutical's pink sheet. These opinions can provide insight into COSMOS Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in COSMOS Pink Sheet
If you are still planning to invest in COSMOS Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the COSMOS Pharmaceutical's history and understand the potential risks before investing.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |